Swings in Robotic Performance: Q222 CAS Spine Market Recap

A market fraught with challenging hospital budgets, chip shortages and continued staffing issues results in apparent swings in robotic performance. On the other hand, enabling tech platforms companies continue to report positive momentum moving into H222.

The Q222 WW CAS Spine Market was down YoY according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader, followed by Globus* (GMED) and other enabling tech competitors including Stryker* (SYK) and Brainlab*. For detailed Q222 revenues and shares by company in the US, EU and ROW, see SmartTRAK CAS Spine Financial Dashboard*.

Among the many topics covered in detail in our comprehensive Q222 Computer Assisted Surgery Spine Market Recap* are:

• Complete Q222 CAS Spine Market Overview and Highlights
• SmartTRAK's Expert Analysis and Insights
• All Company News including Revenues, Data, Charts and Shares
• Variable Robotics Performance in a Difficult Climate
• Enabling Tech Solutions Continue to Gain Traction
• Other Selected Q222 Highlights

Following what Medtronic* highlighted as “record-breaking quarters” in StealthStation* navigation and Mazor* robotics, management noted that in this quarter, component shortage disruptions, particularly semiconductors, affected performance. Additionally, MDT noted healthcare labor shortages and lingering effects of Covid-related cancellations and ...

Read the entire Q222 CAS Spine Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, just click the button below.